(Q46136553)
Statements
1 reference
Natalizumab is effective as second line therapy in the treatment of relapsing remitting multiple sclerosis (English)
1 reference
H C Diener
1 reference
N Putzki
1 reference
K Kollia
1 reference
S Woods
1 reference
E Igwe
1 reference
V Limmroth
1 reference
1 March 2009
1 reference
16
1 reference
3
1 reference
424-426
1 reference